Cell-mediated immunity in chronic myelocytic leukemia

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Chronic myelocytic leukemia (CML) is a myeloproliferative neoplasm.
• Immune system dysregulation is observed in various cancers.
• Understanding immune status in CML is crucial for patient management.

Purpose of the Study:

• To evaluate the immunological status of patients with chronic myelocytic leukemia.
• To investigate potential defects in cellular immune response in vitro and in vivo.

Main Methods:

• Immunological evaluation of 14 CML patients.
• Assessment of lymphocyte percentage and absolute counts.
• Analysis of T lymphocyte percentage and absolute values.
• Phytohemagglutinin (PHA) transformation assays.
• Short-term lymphocyte culture and spontaneous transformation assessment.
• In vivo cellular immunity assessment via skin testing.

Main Results:

• No significant difference in mean lymphocyte percentage or absolute number compared to healthy subjects.
• Decreased T lymphocyte percentage in 28.5% and absolute values in 14.2% of patients.
• Reduced PHA transformation response in 57% of patients.
• Elevated spontaneous lymphocyte transformation in 65% of patients.
• All patients demonstrated positive skin test reactivity.
• Evidence of defective in vitro cellular immune response in most patients.

Conclusions:

• CML patients frequently exhibit defective in vitro cellular immunity.
• The observed immune defect is likely related to qualitative abnormalities in T lymphocyte subpopulations.
• Busulfan therapy may contribute to some of the observed lymphocyte alterations.